These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3118589)

  • 21. [Randomized, double blind, multicentre, parallel group study to compare efficacy and safety of acemetacin and indometacin in patients with activated osteoarthrosis of the knee].
    Gallacchi G; Hodinka L
    Praxis (Bern 1994); 2009 Jun; 98(12):635-42. PubMed ID: 19513973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind, comparative study of diflunisal and naproxen in the treatment of rheumatoid arthritis.
    Devereaux MD; Douglas WA
    Eur J Rheumatol Inflamm; 1983; 6(3):274-8. PubMed ID: 6391932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between cyclosporin A and nonsteroidal antiinflammatory drugs.
    Tugwell P; Ludwin D; Gent M; Roberts R; Bensen W; Grace E; Baker P
    J Rheumatol; 1997 Jun; 24(6):1122-5. PubMed ID: 9195520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter double-blind randomized clinical trial of imidazole salicylate versus ibuprofen in patients with rheumatoid arthritis.
    DiPerri T; Auteri A; Fumagalli M; Gandini R; Giordano A; Giordano M; Scaricabarozzi I; Vaiani G; Vatti M
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):443-7. PubMed ID: 3308719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ranitidine ameliorates acemetacin and indomethacin-induced changes of the gastroduodenal mucosa, without modifying the pharmacokinetic behavior of both antirheumatic drugs].
    Müller P; Dammann HG; Langer M; Leucht U; Simon B
    Z Gastroenterol; 1989 Feb; 27(2):83-6. PubMed ID: 2658392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical profile of acemetacin].
    Rechziegler H; Thebud-Lassak R
    Med Klin (Munich); 1990 May; 85(5):340-6, 352. PubMed ID: 2192250
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in the serum pepsinogen level during therapy with acemtacin retard as a measure of gastroduodenal tolerance].
    Kullich W; Klein G
    Wien Med Wochenschr; 1991; 141(15):331-5. PubMed ID: 1949833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acemetacin antinociceptive mechanism is not related to NO or K+ channel pathways.
    Gil-Flores M; Ortiz MI; Castañeda-Hernández G; Chávez-Piña AE
    Methods Find Exp Clin Pharmacol; 2010 Mar; 32(2):101-5. PubMed ID: 20401346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Open clinical study on the efficacy and tolerance of acemetacin in rheumatoid arthritis and osteoarthrosis].
    Gospodinoff A; Fiore L; Dardano B; Fiore D; Scapato P
    Clin Ter; 1989 Jul; 130(2):109-13. PubMed ID: 2529083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical studies of the interaction between tolmetin and glibenclamide.
    Chlud K; Kaik B
    Int J Clin Pharmacol Biopharm; 1977 Sep; 15(9):409-10. PubMed ID: 410740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The therapeutic activity of 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid monohydrate glucosamide in rheumatoid arthritis (double blind trial).
    Giordano M; Capelli L; Chianese U
    Arzneimittelforschung; 1975 Mar; 25(3):435-7. PubMed ID: 1098671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acemetacin (Emflex)--yet another NSAID.
    Drug Ther Bull; 1991 Sep; 29(20):78. PubMed ID: 1935592
    [No Abstract]   [Full Text] [Related]  

  • 33. Acemetacin in the long-term therapy of rheumatoid arthritis.
    Hazleman B; Bernstein RM
    Curr Med Res Opin; 1993; 13(2):119-26. PubMed ID: 8325042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acemetacin-induced fixed drug eruption.
    Cebeci F; Yaşar Ş; Aytekin S; Güneş P
    Indian J Pharmacol; 2016; 48(2):219-20. PubMed ID: 27114641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double blind trial involving: Teorema, a new antirheumatic, vs. indometacin in rheumatoid diseases.
    Petera P; Tausch G; Bröll H; Eberl R
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):581-4. PubMed ID: 340390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Unwanted modification of the thyroid gland by drugs with special reference to nonsteroidal antirheumatic agents].
    Hambsch K; Löbe M; Ludewig R; Müller P; Herrmann F; Sorger D
    Z Gesamte Inn Med; 1986 Mar; 41(6):181-4. PubMed ID: 3087075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of periarticular ossification--with results of a randomized, double-blind study comparing acemetacin versus indomethacin].
    Gierse H; Eisebitt R; Bernard I
    Z Orthop Ihre Grenzgeb; 1997; 135(5):417-21. PubMed ID: 9446434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acemetacin in patients with rheumatic disease with concomitant liver diseases. Pharmacokinetics, effectiveness and tolerance].
    Seissiger L; Dell HD
    Z Rheumatol; 1987; 46 Suppl 1():65-9. PubMed ID: 3439372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acemetacin in the treatment of rheumatic diseases: an open, multi-centre trial.
    Rechziegler H; Zündorf P
    Curr Med Res Opin; 1985; 9(10):701-7. PubMed ID: 3907990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Milestones in clinical pharmacology. The first nonsteroidal anti-inflammatory drug: a cacophonous birth.
    Pinals RS
    Clin Ther; 1992; 14(5):756-8; discussion 755. PubMed ID: 1468092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.